{"product_id":"omega-3-fish-oil-2000mg-epa-dha","title":"Omega-3 Fish Oil 2000mg | High EPA\/DHA | Cardiovascular \u0026 Brain Longevity","description":"\u003cp\u003e\u003cstrong\u003e2000 mg of wild-caught fish oil per softgel\u003c\/strong\u003e, standardized to deliver \u003cstrong\u003e720 mg EPA + 480 mg DHA\u003c\/strong\u003e in the clinically-studied 3:2 ratio. Triglyceride-form (rTG), molecularly distilled, third-party tested for heavy metals and PCBs, in a small enteric-coated softgel — no fishy reflux, no aftertaste. The single nutrient with more peer-reviewed cardiovascular and brain-longevity research behind it than anything else in this catalog.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy people take it:\u003c\/strong\u003e long-chain omega-3s (EPA + DHA) lower triglycerides 20–30% (Skulas-Ray 2019, AHA Science Advisory), reduce systemic inflammation (Calder 2017), and physically build the phospholipid membranes of every neuron, retinal cell, and cardiomyocyte you own.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat it’s NOT:\u003c\/strong\u003e not flaxseed oil. ALA-to-EPA conversion in humans is 1–10% (Burdge 2002), and ALA-to-DHA is closer to 0.5%. If your goal is a measurable Omega-3 Index, fish oil is the only practical route — or algal oil for vegans.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe form matters:\u003c\/strong\u003e triglyceride (TG \/ re-esterified TG) is absorbed roughly 70% better than ethyl-ester (EE) over 6 months (Dyerberg 2010, Neubronner 2011). Most pharmacy fish oil is EE because it’s cheaper to concentrate. Ours is rTG.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 2 softgels = 1,440 mg EPA + 960 mg DHA. The dose used in REDUCE-IT (Bhatt 2019, NEJM) was 4 g\/day icosapent ethyl, but every dose-response analysis (Skulas-Ray 2019, Mozaffarian 2011) shows clear cardiovascular signal starting at ≈1 g\/day combined EPA+DHA.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTimeline:\u003c\/strong\u003e Omega-3 Index moves measurably in 8–12 weeks. Triglycerides move in 4–6 weeks. Joint and mood signal in 8–16 weeks. Cardiovascular event reduction is a multi-year endpoint.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhere it sits in this catalog:\u003c\/strong\u003e alongside \u003ca href=\"\/products\/vitamin-d3-5000-iu-with-k2-mk7-100mcg\"\u003eVitamin D3 5000 IU + K2 MK-7 100mcg\u003c\/a\u003e and \u003ca href=\"\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg TRAACS\u003c\/a\u003e, this is one of the three foundational supplements that earn their place in essentially every healthspan protocol — the always-on layer underneath your \u003ca href=\"\/collections\/nad-family\"\u003eNAD+ stack\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy omega-3s sit at the foundational layer\u003c\/h2\u003e\n\u003cp\u003eMost longevity stacks chase mechanisms — sirtuins, mitophagy, NAD+ precursors, senolytics. Omega-3s are different: they are a \u003cem\u003estructural\u003c\/em\u003e intervention. Every cell membrane in your body is built from a phospholipid bilayer, and the fatty acids on the “sn-2” position of those phospholipids dictate how the membrane behaves — how fluid it is, how it folds, how its receptors signal, and what eicosanoids it releases when injured.\u003c\/p\u003e\n\u003cp\u003eEPA and DHA compete with arachidonic acid (the omega-6 you get from seed oils, conventional poultry, and processed food) for incorporation into those membranes. When dietary EPA\/DHA is low and arachidonic acid is high — the default modern Western pattern — cells generate predominantly pro-inflammatory eicosanoids: 2-series prostaglandins, 4-series leukotrienes, thromboxane A2. When EPA\/DHA replace arachidonic acid in the membrane, the same enzymes (COX, LOX) instead generate \u003cstrong\u003e3-series prostaglandins, 5-series leukotrienes, and the entire Specialized Pro-resolving Mediator (SPM) family\u003c\/strong\u003e — resolvin E1\/E2, resolvin D1-D6, protectin D1, maresin 1 — which actively terminate inflammation rather than amplify it (Serhan 2014, Nature; Calder 2017).\u003c\/p\u003e\n\u003cp\u003eThis is why omega-3 supplementation has measurable effects across 12+ unrelated organ systems: it’s not a drug acting on one receptor — it’s a building material that changes the \u003cem\u003eresolution\u003c\/em\u003e capacity of every membrane in the body.\u003c\/p\u003e\n\n\u003ch2\u003eThe Omega-3 Index — the only blood marker that matters here\u003c\/h2\u003e\n\u003cp\u003eThe \u003cstrong\u003eOmega-3 Index\u003c\/strong\u003e (Harris \u0026amp; von Schacky 2004, Prev Med) is the percentage of EPA + DHA in red blood cell membrane phospholipids. It’s the cleanest single biomarker for omega-3 status because RBC membranes turn over slowly (≈120 days) and reflect long-term incorporation rather than the previous meal.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u0026lt; 4%\u003c\/strong\u003e — high cardiovascular risk zone. The U.S. average sits in this range. Sudden cardiac death risk roughly 10x vs \u0026gt;8% (Albert 2002, NEJM, n=22,071 male physicians).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e4–8%\u003c\/strong\u003e — intermediate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u0026gt; 8%\u003c\/strong\u003e — cardioprotective range. This is the level epidemiologically associated with the lowest all-cause mortality in the Framingham Offspring follow-up (Harris 2018, J Clin Lipidol, n=2,500, 11-year follow-up: each 1% Omega-3 Index increase associated with 13% lower all-cause mortality).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e2 softgels\/day of this product (1.44 g EPA + 0.96 g DHA) typically moves the Omega-3 Index from the 3–5% Western baseline into the 8–10% range over 12–16 weeks (Flock 2013, J Lipid Res — dose-response curve). 3–4 softgels move it faster but plateau in the same range.\u003c\/p\u003e\n\n\u003ch2\u003eTriglyceride vs ethyl ester — why the form on the label is non-negotiable\u003c\/h2\u003e\n\u003cp\u003eNative fish oil is in \u003cstrong\u003etriglyceride (TG) form\u003c\/strong\u003e — three fatty acids attached to a glycerol backbone, just as they exist in fish flesh. To concentrate EPA and DHA above the ≈30% native ratio (most fish oil starts there), manufacturers add ethanol, releasing fatty acids as \u003cstrong\u003eethyl esters (EE)\u003c\/strong\u003e. EE allows molecular distillation up to \u0026gt;90% EPA+DHA but produces a synthetic form that the gut absorbs differently:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLipase activity:\u003c\/strong\u003e pancreatic lipase hydrolyzes TG roughly 10–50x faster than EE (Yang 1990, Biochim Biophys Acta).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e6-month bioavailability:\u003c\/strong\u003e rTG produces 70% higher RBC incorporation than EE at the same dose (Dyerberg 2010, Prostaglandins Leukot Essent Fatty Acids; Neubronner 2011 same-design replication).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eReflux\/burping:\u003c\/strong\u003e EE generates ethanol on hydrolysis and tends to produce more “fish-oil reflux.”\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e rTG is more oxidation-resistant than free fatty acid (FFA) form, less so than EE.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRe-esterified TG (rTG) is EE that has been enzymatically converted back to TG form — you get the concentration of EE plus the absorption of native TG. Most premium fish oil is rTG. Ours is rTG. Most U.S. pharmacy and big-box brands are EE because the regulatory pathway and unit cost are cheaper. Read the label; if it doesn’t specifically say “triglyceride form” or “rTG,” assume EE.\u003c\/p\u003e\n\n\u003ch2\u003eThe clinical evidence — six domains, not just heart\u003c\/h2\u003e\n\n\u003ch3\u003e1. Cardiovascular\u003c\/h3\u003e\n\u003cp\u003eThe cardiovascular evidence is the largest and most contentious in nutrition science. The high-level synthesis:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGISSI-Prevenzione (Marchioli 1999, Lancet):\u003c\/strong\u003e 11,324 post-MI patients, 850 mg\/day EPA+DHA, 3.5 years — 20% all-cause mortality reduction, 45% sudden cardiac death reduction. The trial that put fish oil on every cardiology guideline.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eJELIS (Yokoyama 2007, Lancet):\u003c\/strong\u003e 18,645 Japanese hypercholesterolemics, 1.8 g\/day EPA-only on top of statins, 4.6 years — 19% major coronary event reduction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eREDUCE-IT (Bhatt 2019, NEJM):\u003c\/strong\u003e 8,179 high-risk patients with elevated triglycerides, 4 g\/day icosapent ethyl (high-purity EPA), 4.9 years — \u003cstrong\u003e25% reduction\u003c\/strong\u003e in composite cardiovascular events. The strongest modern signal, and the basis for the FDA approval of icosapent ethyl as an Rx drug.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVITAL (Manson 2019, NEJM):\u003c\/strong\u003e 25,871 healthy U.S. adults, 1 g\/day EPA+DHA, 5.3 years — no change in primary composite, but a 28% reduction in MI in the “low fish intake” subgroup, suggesting baseline status matters.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSTRENGTH (Nicholls 2020, JAMA):\u003c\/strong\u003e EPA+DHA carboxylic acid form failed to reduce CV events vs corn oil placebo. The negative trial that complicates the EPA-only narrative.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTriglyceride lowering:\u003c\/strong\u003e meta-analyzed across 70+ RCTs, 2–4 g\/day EPA+DHA lowers TG 20–30% in normolipidemic and up to 45% in hypertriglyceridemic patients (Skulas-Ray 2019, AHA Science Advisory).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe honest read: the evidence for triglyceride-lowering and Omega-3 Index improvement is unambiguous; the evidence for hard cardiovascular outcomes is dose-, form-, and population-dependent. The dose used in REDUCE-IT (4 g\/day high-purity EPA) is what produced the strongest signal. Your 2-softgel dose here is the foundational maintenance dose, not the pharmacological-event-reduction dose.\u003c\/p\u003e\n\n\u003ch3\u003e2. Brain \u0026amp; cognition\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eDHA is ≈30% of all gray matter fatty acids\u003c\/strong\u003e (Bradbury 2011, Nutrients) and is concentrated in synaptic membranes. Adult brain DHA turnover is slow but real, and dietary supply matters because de novo synthesis from ALA is \u0026lt;0.5%.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMIDAS (Yurko-Mauro 2010, Alzheimers Dement):\u003c\/strong\u003e 485 healthy older adults, 900 mg DHA\/day, 24 weeks — episodic memory improved equivalent to roughly 3 years of cognitive aging reversal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSmith 2010, PLoS One:\u003c\/strong\u003e B-vitamin trial in MCI showed brain atrophy slowed only in subjects with high baseline omega-3 status — a treatment-effect-modifier signal that’s been replicated in the OmegAD and AlphaOmega trials.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePottala 2014, Neurology:\u003c\/strong\u003e Omega-3 Index correlated with total brain volume and hippocampal volume in 1,111 women in the WHIMS-MRI cohort.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBDNF \/ synaptic plasticity:\u003c\/strong\u003e DHA upregulates BDNF and supports LTP in hippocampal preparations (Wu 2008, Neuroscience). The mechanistic story behind the cognitive trial signal.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003e3. Mood \u0026amp; mental health\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eEPA — not DHA — carries the depression signal.\u003c\/strong\u003e Meta-analyses repeatedly show that EPA-predominant formulations (\u0026gt;60% EPA) reduce depressive symptoms while DHA-predominant ones do not (Sublette 2011, J Clin Psychiatry; Mocking 2016 meta-analysis, Transl Psychiatry, n=1,233 patients across 13 RCTs — effect size SMD −0.40 with EPA-predominant). Our 3:2 EPA:DHA ratio is on the EPA-predominant side.\u003c\/p\u003e\n\n\u003ch3\u003e4. Eye health\u003c\/h3\u003e\n\u003cp\u003eThe retina has the highest DHA concentration of any tissue in the body — outer-segment photoreceptor membranes are ≈50% DHA. The AREDS2 trial (NIH-funded, n=4,203, 5 years) tested DHA + EPA on AMD progression and found no significant primary effect, but multiple smaller trials show benefit on dry eye symptoms (Bhargava 2013), tear film stability, and Meibomian gland function.\u003c\/p\u003e\n\n\u003ch3\u003e5. Joints \u0026amp; inflammation\u003c\/h3\u003e\n\u003cp\u003eOmega-3s are the most-studied non-NSAID joint intervention.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMaroon \u0026amp; Bost 2006, Surg Neurol:\u003c\/strong\u003e 1,200 mg EPA+DHA\/day, 250 patients with chronic neck\/back pain — 60% reduced or eliminated NSAIDs at 75 days.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGoldberg \u0026amp; Katz 2007 meta-analysis, Pain:\u003c\/strong\u003e 17 RCTs, omega-3s reduced morning stiffness, joint swelling, and NSAID consumption in inflammatory joint pain.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMechanism:\u003c\/strong\u003e resolvins and protectins actively terminate the inflammatory phase rather than just blocking COX. This is why the effect builds over months rather than within hours like NSAIDs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003e6. Metabolic \/ liver\u003c\/h3\u003e\n\u003cp\u003eOmega-3s lower hepatic triglyceride content via SREBP-1c suppression and PPAR-α activation. Multiple meta-analyses show 2–4 g\/day EPA+DHA reduces liver fat 20–40% in NAFLD (Parker 2012, J Hepatol meta-analysis of 9 RCTs, n=355). HDL typically rises slightly; LDL rises modestly in some patients (the so-called “LDL paradox”), driven by a shift toward larger, less atherogenic LDL particles.\u003c\/p\u003e\n\n\u003ch2\u003eEPA vs DHA — what each one actually does\u003c\/h2\u003e\n\u003ctable style=\"width:100%; border-collapse:collapse; margin:1em 0;\"\u003e\n\u003cthead\u003e\n\u003ctr style=\"background:#f6f6f6;\"\u003e\n\u003cth style=\"padding:8px; border:1px solid #ddd; text-align:left;\"\u003eFunction\u003c\/th\u003e\n\u003cth style=\"padding:8px; border:1px solid #ddd; text-align:left;\"\u003eEPA (20:5 ω-3)\u003c\/th\u003e\n\u003cth style=\"padding:8px; border:1px solid #ddd; text-align:left;\"\u003eDHA (22:6 ω-3)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eTriglyceride lowering\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eStrong\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eSlightly stronger\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eAnti-inflammatory (resolvin E1\/E2)\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003ePrimary substrate\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eSecondary\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eResolvin D \/ Protectin \/ Maresin\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eNo\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003ePrimary substrate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eMood \/ depression signal\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eStrong (Mocking 2016)\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eWeak\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eCognitive \/ memory signal\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eModest\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eStrong (Yurko-Mauro 2010)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eRetinal \u0026amp; neural membrane structure\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eMinor\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003ePrimary structural fatty acid\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003ePregnancy \/ infant brain development\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eSupportive\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eCritical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eCardiovascular event reduction (REDUCE-IT)\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eStrong (high-dose)\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eLikely additive\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe 3:2 EPA:DHA ratio in this product (720 mg : 480 mg) is the ratio used in the largest cardiovascular trials including GISSI-Prevenzione — a balanced foundational profile that captures both the EPA-driven inflammation\/triglyceride\/mood story and the DHA-driven neural\/retinal\/membrane story. If your goal is purely depression-targeting you’d want pure EPA; if it’s purely pregnancy\/infant brain you’d want pure DHA; if it’s general healthspan, balanced is correct.\u003c\/p\u003e\n\n\u003ch2\u003eWhat’s in each softgel\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWild-caught fish oil concentrate:\u003c\/strong\u003e 2,000 mg, sourced from anchovy, sardine, and mackerel (low-trophic-level species — minimum bioaccumulation of mercury and PCBs).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEPA (eicosapentaenoic acid):\u003c\/strong\u003e 720 mg, in re-esterified triglyceride (rTG) form.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDHA (docosahexaenoic acid):\u003c\/strong\u003e 480 mg, rTG form.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOther omega-3s:\u003c\/strong\u003e ≈100 mg DPA (docosapentaenoic acid), the “forgotten” intermediate omega-3 with its own resolvin pathway.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntioxidant package:\u003c\/strong\u003e mixed natural tocopherols (vitamin E) to prevent in-bottle oxidation. No synthetic BHT\/BHA.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEnteric coating:\u003c\/strong\u003e the softgel is enteric-coated so it dissolves in the small intestine, not the stomach — the single most effective fix for the “fishy reflux” problem.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat’s NOT in it:\u003c\/strong\u003e no titanium dioxide, no artificial colors, no soybean oil filler (a common label trick in budget fish oil), no proprietary blends.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eQuality, sourcing, and oxidation\u003c\/h2\u003e\n\u003cp\u003eFish oil is a peroxidation-vulnerable product. The clinical-grade signals to look for:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMolecular distillation\u003c\/strong\u003e — multi-stage vacuum process that removes mercury, PCBs, dioxins, and PFAS to below the most stringent international standards (CRN, GOED Voluntary Monograph, IFOS 5-star).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeroxide value (PV) \u0026lt; 5 meq\/kg\u003c\/strong\u003e and \u003cstrong\u003ep-Anisidine value (p-AV) \u0026lt; 20\u003c\/strong\u003e — both measures of oxidation. Industry-grade rancidity is – at minimum — PV \u0026gt; 5 or p-AV \u0026gt; 20. Multiple supermarket brands fail this on independent testing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTOTOX (total oxidation) \u0026lt; 26\u003c\/strong\u003e — the combined freshness metric.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeavy metals:\u003c\/strong\u003e Hg, Pb, As, Cd all under USP \u0026lt;232\u0026gt; limits, third-party verified per batch.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMarine-traceable sourcing:\u003c\/strong\u003e small forage fish (anchovy, sardine, mackerel) — not large predators (tuna, swordfish, shark) where mercury and PCBs concentrate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNitrogen-flushed fill\u003c\/strong\u003e and \u003cstrong\u003eUV-protected amber bottle\u003c\/strong\u003e — both reduce in-bottle oxidation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ecGMP-manufactured, FDA-registered facility\u003c\/strong\u003e — per-batch certificate of analysis available on request.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow to take it\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStandard dose:\u003c\/strong\u003e 2 softgels daily with the largest meal of the day. Fat-meal absorption \u0026gt; light\/empty-stomach absorption (Lawson 1988, Biochem Biophys Res Commun — the original observation; Davidson 2012 NEJM letter on the same effect with prescription EPA).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHigher-dose protocol:\u003c\/strong\u003e 3–4 softgels daily for elevated triglycerides, active inflammatory pain, or aggressive Omega-3 Index targeting. Monitor with a finger-prick Omega-3 Index test at week 12 (DHL OmegaQuant or equivalent).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTiming:\u003c\/strong\u003e any consistent timing works; with-food matters more than morning vs evening. The 24-hour pharmacokinetic curve is flat at steady state.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you take a blood thinner\u003c\/strong\u003e (warfarin, apixaban, rivaroxaban, clopidogrel): omega-3 prolongs bleeding time modestly at high doses (\u0026gt;3 g\/day). The clinical evidence for actual bleeding events at maintenance doses is weak (Wachira 2014 meta-analysis, Mayo Clin Proc; ACC\/AHA 2019 guidelines explicitly do not recommend stopping fish oil pre-procedure for \u0026lt;3 g\/day). Talk to your prescriber.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSurgery:\u003c\/strong\u003e some surgeons request a 7–14 day stop pre-op out of caution. Follow your surgical team’s protocol.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e cool, dark, dry. Refrigeration extends shelf life beyond the printed expiration. If a softgel ever tastes overtly fishy or rancid, throw out the bottle — it’s oxidized.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat it pairs with — the foundational layer\u003c\/h2\u003e\n\u003ctable style=\"width:100%; border-collapse:collapse; margin:1em 0;\"\u003e\n\u003cthead\u003e\n\u003ctr style=\"background:#f6f6f6;\"\u003e\n\u003cth style=\"padding:8px; border:1px solid #ddd; text-align:left;\"\u003ePair\u003c\/th\u003e\n\u003cth style=\"padding:8px; border:1px solid #ddd; text-align:left;\"\u003eWhy\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/products\/vitamin-d3-5000-iu-with-k2-mk7-100mcg\"\u003eVitamin D3 5000 IU + K2 MK-7\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eThe two highest-deficiency-prevalence interventions in the modern Western diet. Both fat-soluble — same meal, same softgel slot. The cardiovascular and bone evidence stacks rather than overlaps.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg TRAACS\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eCardiovascular triad complete: omega-3 lowers TG and inflammation, Vitamin D supports calcium handling, magnesium handles arterial smooth-muscle tone and NAMPT cofactor duty. Fang 2016 mortality meta + GISSI overlap.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/products\/astaxanthin-12mg-haematococcus-pluvialis\"\u003eAstaxanthin 12mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eThe single best in-membrane antioxidant for protecting omega-3 phospholipids from peroxidation. Astaxanthin spans the lipid bilayer (one polar end, one nonpolar end) and physically shields PUFA double bonds. The classical “DHA + astaxanthin” pair.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/products\/coq10-fertility-cellular-energy-support\"\u003eCoQ10 400mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eCardiovascular pair. CoQ10 is mitochondrial-membrane-resident; omega-3s rebuild the membrane it sits in. Lipid-soluble — co-dose with same fat meal.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/products\/curcumin-1000mg-95-curcuminoids-with-bioperine\"\u003eCurcumin 1000mg + BioPerine\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eAnti-inflammatory pair via two non-overlapping mechanisms — omega-3s shift eicosanoid output from pro-inflammatory to pro-resolving; curcumin inhibits NF-κB \/ COX-2 directly. Strongest joint-pain evidence in combination.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\n\u003ca href=\"\/products\/glutathione-500mg-reduced-gsh-enteric-coated\"\u003eGlutathione 500mg (enteric)\u003c\/a\u003e \u0026amp; \u003ca href=\"\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eLipid peroxidation defense. PUFAs are the fuel for membrane peroxidation; glutathione (and the NAC GlyNAC pair) is the primary regeneration system. Without GSH support, high-dose fish oil + low-antioxidant intake is suboptimal.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\n\u003ca href=\"\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e \/ \u003ca href=\"\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eNAD+ stack pairs with omega-3 mechanistically: NAD+ supports mitochondrial ATP throughput, omega-3 supplies the membrane phospholipids those mitochondria sit in. Without omega-3 substrate, mitochondrial membranes drift toward stiff, arachidonic-acid-rich profiles even with abundant NAD+.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/products\/multi-collagen-complex-types-i-ii-iii-v-x-240-capsules\"\u003eMulti Collagen Complex\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eJoint pair. Collagen is the structural protein; omega-3 is the inflammation modulator. The two address different sides of the same pathology — cartilage matrix supply + synovial inflammation resolution.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eUniversal antioxidant pair. ALA recycles vitamin C, vitamin E, and glutathione — all three of which protect omega-3 PUFAs from peroxidation. The complete antioxidant umbrella for any high-PUFA intake.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\n\u003ca href=\"\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen Peptides 5000mg\u003c\/a\u003e + \u003ca href=\"\/products\/biotin-10000-mcg-maximum-strength\"\u003eBiotin 10,000mcg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eSkin\/hair\/nails triad. DHA is structural in skin barrier ceramide synthesis; collagen and biotin are the matrix and growth-phase complements. The dermatology stack.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eWhat to expect — realistic timeline\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 1–2:\u003c\/strong\u003e usually no felt change. Some people notice softer stools (mild lipid laxation) or a one-week period of mild fish-oil reflux that resolves once the enteric coating is acclimated. Triglycerides start to decline but you wouldn’t lab-detect it yet.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–6:\u003c\/strong\u003e measurable triglyceride drop (lab a fasting lipid panel at week 6 if you want a number). Some users notice less morning joint stiffness. Mood signal — if any — starts here in the EPA-responsive subgroup.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12:\u003c\/strong\u003e Omega-3 Index moves measurably (re-test at week 12 with a finger-prick kit). Joint, skin barrier, and dry-eye signals consolidate. Cognitive signal — if any — starts here.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3–6:\u003c\/strong\u003e the membrane composition is now fully turned over. This is the steady-state phase — omega-3 is doing what it does for you, whatever that turns out to be in your particular biology.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYear 1+:\u003c\/strong\u003e the cardiovascular and cognitive endpoints in the long-term cohorts (Framingham Offspring, AlphaOmega, MIDAS open-label extension) are measured in years, not weeks. Maintenance is the strategy, not pulse-dosing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat NOT to expect:\u003c\/strong\u003e not a stimulant, not a quick fix, not a weight-loss agent (modest at best), not a substitute for omega-6 reduction (vegetable oils still matter), not a substitute for blood pressure or lipid medication if your numbers are deep into clinical-treatment range.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAnyone whose dietary fish intake is \u0026lt;2 servings\/week of fatty fish — which is most adults outside coastal Asia and the Mediterranean.\u003c\/li\u003e\n  \u003cli\u003eAnyone running an \u003ca href=\"\/collections\/nad-family\"\u003eNAD+ stack\u003c\/a\u003e, sirtuin stack, or longevity protocol — omega-3 is the foundational substrate underneath those interventions.\u003c\/li\u003e\n  \u003cli\u003eAdults 40+ thinking about cardiovascular and cognitive trajectory.\u003c\/li\u003e\n  \u003cli\u003ePostmenopausal women: omega-3 status correlates with hippocampal and total brain volume in WHIMS-MRI; the period of most-rapid bone and brain aging.\u003c\/li\u003e\n  \u003cli\u003eAthletes and high-training-load individuals managing chronic low-grade inflammation.\u003c\/li\u003e\n  \u003cli\u003ePeople with elevated triglycerides (\u0026gt;150 mg\/dL) for whom dietary change alone hasn’t moved the number.\u003c\/li\u003e\n  \u003cli\u003eAnyone with a family history of premature cardiovascular disease — the highest-leverage intervention category in the entire VITAL\/REDUCE-IT\/JELIS literature.\u003c\/li\u003e\n  \u003cli\u003ePeople with chronic joint pain or low-grade inflammation looking to reduce NSAID load.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFish allergy:\u003c\/strong\u003e this is a fish-derived product. A vegan algal-DHA product is the alternative.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive anticoagulation\u003c\/strong\u003e at high doses: 1–2 g\/day combined EPA+DHA appears safe in the meta-analyzed evidence even on warfarin\/DOAC; doses \u0026gt;3 g\/day in this context warrant prescriber discussion.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-surgery (\u0026lt; 7–14 days):\u003c\/strong\u003e follow your surgical team’s instructions. Most current cardiology guidance does not require a stop, but practice varies by surgeon.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy:\u003c\/strong\u003e DHA is critical for fetal brain development — but pregnancy supplementation should be guided by your OB, ideally with a low-mercury algal DHA product or a doctor-supervised fish oil protocol. This product is not labeled for pregnancy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAtrial fibrillation history:\u003c\/strong\u003e very-high-dose icosapent ethyl in REDUCE-IT modestly increased AF events. Standard 1–2 g\/day combined EPA+DHA carries no comparable signal in maintenance trials, but if you have known AF, raise it with your cardiologist before going to 3–4 g\/day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChronic GI fat malabsorption\u003c\/strong\u003e (severe pancreatic insufficiency, advanced IBD with steatorrhea): rTG fish oil still requires lipase. Speak with your GI team about phospholipid-form omega-3 (krill, herring roe) which is partially absorbed without lipase.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eIs this triglyceride form (TG\/rTG) or ethyl ester (EE)?\u003c\/strong\u003e\u003cbr\u003e\nRe-esterified triglyceride (rTG). The form with the best long-term bioavailability data (Dyerberg 2010, Neubronner 2011) and the form most premium fish oil brands use. If you’ve compared labels and seen the EE\/TG distinction, this is on the rTG side.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy is the dose 1,200 mg EPA+DHA at 2 softgels rather than 4 g like REDUCE-IT?\u003c\/strong\u003e\u003cbr\u003e\nREDUCE-IT used 4 g\/day icosapent ethyl (high-purity EPA) in patients with elevated triglycerides on statins as a pharmacologic intervention. The 1,200 mg combined EPA+DHA dose (or 2,400 mg at 4 softgels) is the maintenance dose used in the foundational Omega-3 Index literature and in GISSI-Prevenzione. If your goal is post-MI cardioprotection or aggressive triglyceride lowering, 4 softgels\/day = 2,880 mg combined EPA+DHA is closer to the trial-equivalent dose. For general healthspan, 2 softgels.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow does this compare to flaxseed oil or chia?\u003c\/strong\u003e\u003cbr\u003e\nFlax\/chia provide ALA, the short-chain plant omega-3. ALA-to-EPA conversion in humans is 1–10%; ALA-to-DHA is 0.5% or less (Burdge 2002, Br J Nutr). If your goal is moving the Omega-3 Index, flax does it inefficiently. Algal oil (DHA-only or DHA+EPA) is the legitimate vegan alternative.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow does this compare to krill oil?\u003c\/strong\u003e\u003cbr\u003e\nKrill provides phospholipid-form omega-3 plus astaxanthin, both at lower per-capsule EPA+DHA than fish oil. Phospholipid form has a small absorption advantage in some studies (Schuchardt 2011); the per-mg cost is higher; the krill stocks are managed but ecologically debated. For matched EPA+DHA delivery, fish oil is more cost-efficient. The classical “fish oil + standalone \u003ca href=\"\/products\/astaxanthin-12mg-haematococcus-pluvialis\"\u003eastaxanthin\u003c\/a\u003e” pair gives you both in measured doses.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill this raise my LDL?\u003c\/strong\u003e\u003cbr\u003e\nIn some individuals, particularly with high baseline triglycerides, omega-3 raises LDL-C modestly. This is largely a particle-size shift (fewer small dense LDL, more large buoyant LDL) which is metabolically favorable, not a true atherogenic burden increase. ApoB and LDL-P are the better markers. Re-test ApoB at week 12 if this question matters to you.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat about “burping fish”?\u003c\/strong\u003e\u003cbr\u003e\nThree causes: oxidized oil (the bottle is rancid — throw it out), gastric-dissolution softgels (no enteric coating), and large dose on empty stomach. Enteric coating on this product addresses #2; with-food dosing addresses #3; cool-dark storage addresses #1.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow much mercury \/ heavy metal is in fish oil?\u003c\/strong\u003e\u003cbr\u003e\nIn a properly molecularly-distilled product, all heavy metals are below detection limits per USP \u0026lt;232\u0026gt;. Mercury bioaccumulates in fish flesh, not fish oil — the distillation process strips it almost entirely. Anchovy\/sardine\/mackerel are low-trophic-level forage fish that don’t accumulate much to begin with; molecular distillation removes the residual.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eShould I take this with or without food?\u003c\/strong\u003e\u003cbr\u003e\nWith food — particularly with a meal containing some fat — absorption is meaningfully better than empty-stomach (Lawson 1988; Davidson 2012 NEJM letter). Same fat meal as your \u003ca href=\"\/products\/vitamin-d3-5000-iu-with-k2-mk7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e, your \u003ca href=\"\/products\/coq10-fertility-cellular-energy-support\"\u003eCoQ10\u003c\/a\u003e, and your \u003ca href=\"\/products\/astaxanthin-12mg-haematococcus-pluvialis\"\u003eastaxanthin\u003c\/a\u003e if you take them.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with my statin?\u003c\/strong\u003e\u003cbr\u003e\nYes. The cardiovascular evidence for omega-3 is largely on top of statin therapy (JELIS, REDUCE-IT). No pharmacokinetic interaction. Many cardiologists actively co-prescribe.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes fish oil thin the blood — should I stop before surgery?\u003c\/strong\u003e\u003cbr\u003e\nModest effect on bleeding time at high doses; weak evidence for actual bleeding events at maintenance doses. ACC\/AHA 2019 guidelines explicitly do not require pre-procedure cessation at standard doses. Your surgical team may have local policy — follow theirs.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy DPA on the label?\u003c\/strong\u003e\u003cbr\u003e\nDocosapentaenoic acid (22:5 ω-3) is the “forgotten” intermediate omega-3 between EPA and DHA. It’s a precursor to its own resolvin family (Rv-DPA series) and has independent triglyceride and platelet effects (Byelashov 2015). It’s naturally present in marine oils (the ≈100 mg here is native, not added) and is generally not concentrated out of premium products.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow do I know if it’s working?\u003c\/strong\u003e\u003cbr\u003e\nThree options: (1) lab a fasting lipid panel at week 6 and look for triglyceride decline; (2) order a finger-prick Omega-3 Index test at week 12; (3) track subjective endpoints — morning joint stiffness, dry eye, mood, sleep — against a baseline diary. Option 2 is the only truly objective single-data-point readout because the Omega-3 Index reflects the membrane-level intervention you’re actually buying.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eVegan \/ vegetarian alternative?\u003c\/strong\u003e\u003cbr\u003e\nAlgal oil (Schizochytrium-derived DHA, sometimes with EPA) is the legitimate plant-based EPA\/DHA source. Same molecules, different organism, lower aftertaste. We don’t currently stock an algal product but it’s on the catalog roadmap.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this if I have an iodine sensitivity?\u003c\/strong\u003e\u003cbr\u003e\nFish oil contains negligible iodine — iodine concentrates in fish flesh and thyroid, not the oil fraction. Generally compatible with low-iodine diets.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat’s the difference between this and prescription fish oil (Vascepa, Lovaza)?\u003c\/strong\u003e\u003cbr\u003e\nVascepa is icosapent ethyl — pure EPA in ethyl ester form, FDA-approved as a drug. Lovaza is mixed EPA\/DHA in ethyl ester form, FDA-approved. Both are EE not rTG; both are dosed at 2–4 g\/day; both are insurance-billable for triglyceride lowering or for the REDUCE-IT indication. This is not a drug, and the FDA disclaimer below applies. The active fatty acid molecules are the same.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy enteric coating?\u003c\/strong\u003e\u003cbr\u003e\nA standard softgel dissolves in the stomach. If the contents oxidize there or the user is sensitive to fish-oil reflux, “fish burps” happen. An enteric-coated softgel passes intact through the stomach and dissolves in the duodenum, where the oil meets bile acids and lipase under physiological conditions. The reflux\/burp problem largely disappears.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the True Health Protocol catalog\u003c\/h2\u003e\n\u003cp\u003eOmega-3 Fish Oil 2000mg is one of the four foundational always-on supplements in the catalog — alongside \u003ca href=\"\/products\/vitamin-d3-5000-iu-with-k2-mk7-100mcg\"\u003eVitamin D3 + K2\u003c\/a\u003e, \u003ca href=\"\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate TRAACS\u003c\/a\u003e, and the \u003ca href=\"\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e+\u003ca href=\"\/products\/glycine-1500mg-glynac-partner-glutathione-precursor\"\u003eGlycine\u003c\/a\u003e GlyNAC pair. These are the supplements that do not chase a specific pathway but instead supply the structural and cofactor inputs that every other intervention assumes. Without them, an aggressive NMN\/sirtuin\/senolytic stack is being deployed onto a substrate-deficient cellular environment.\u003c\/p\u003e\n\u003cp\u003eThe supplementary anti-inflammatory and joint pairings — \u003ca href=\"\/products\/curcumin-1000mg-95-curcuminoids-with-bioperine\"\u003eCurcumin + BioPerine\u003c\/a\u003e, \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid\"\u003eQuercetin\u003c\/a\u003e, \u003ca href=\"\/products\/multi-collagen-complex-types-i-ii-iii-v-x-240-capsules\"\u003eMulti Collagen Complex\u003c\/a\u003e, \u003ca href=\"\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen Peptides\u003c\/a\u003e — sit on top of the omega-3 substrate. The cardiovascular pairings (\u003ca href=\"\/products\/coq10-fertility-cellular-energy-support\"\u003eCoQ10\u003c\/a\u003e, \u003ca href=\"\/products\/taurine-1000mg-foundational-cardiovascular-mitochondrial\"\u003eTaurine\u003c\/a\u003e) similarly assume omega-3 as the membrane-quality baseline.\u003c\/p\u003e\n\u003cp\u003eThe NAD+ family (\u003ca href=\"\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000\u003c\/a\u003e, \u003ca href=\"\/products\/nmn-500mg-pure-nmn-30-day-supply\"\u003eNMN 500\u003c\/a\u003e, \u003ca href=\"\/products\/liposomal-nad-1000mg-anti-aging-formula\"\u003eLiposomal NAD+ Ultimate\u003c\/a\u003e, \u003ca href=\"\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e) and the senolytic\/sirtuin family (\u003ca href=\"\/products\/fisetin-500mg-mayo-ranked-senolytic-flavonoid\"\u003eFisetin\u003c\/a\u003e, \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid\"\u003eQuercetin\u003c\/a\u003e, \u003ca href=\"\/products\/apigenin-50mg-bioperine-cd38-inhibitor\"\u003eApigenin\u003c\/a\u003e, \u003ca href=\"\/products\/resveratrol-600mg-trans-resveratrol-sirt1-activator\"\u003eResveratrol\u003c\/a\u003e, \u003ca href=\"\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e) layer above this. None of those pathways function correctly with stiff arachidonic-acid-dominated membranes.\u003c\/p\u003e\n\n\u003ch2\u003eThe science (selected references)\u003c\/h2\u003e\n\u003col\u003e\n  \u003cli\u003eMarchioli R et al. \u003cem\u003eGISSI-Prevenzione\u003c\/em\u003e. Lancet 1999;354(9177):447-455. (Post-MI all-cause mortality reduction.)\u003c\/li\u003e\n  \u003cli\u003eYokoyama M et al. \u003cem\u003eJELIS\u003c\/em\u003e. Lancet 2007;369(9567):1090-1098. (EPA on statins, Japanese hyperlipidemic cohort.)\u003c\/li\u003e\n  \u003cli\u003eBhatt DL et al. \u003cem\u003eREDUCE-IT\u003c\/em\u003e. N Engl J Med 2019;380:11-22. (4 g\/day icosapent ethyl, 25% CV event reduction.)\u003c\/li\u003e\n  \u003cli\u003eManson JE et al. \u003cem\u003eVITAL\u003c\/em\u003e. N Engl J Med 2019;380:23-32. (1 g\/day EPA+DHA in healthy U.S. adults, subgroup signal in low-fish-intake stratum.)\u003c\/li\u003e\n  \u003cli\u003eNicholls SJ et al. \u003cem\u003eSTRENGTH\u003c\/em\u003e. JAMA 2020;324(22):2268-2280. (EPA+DHA carboxylic acid, negative primary trial — the complicating result.)\u003c\/li\u003e\n  \u003cli\u003eAlbert CM et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002;346(15):1113-1118.\u003c\/li\u003e\n  \u003cli\u003eSkulas-Ray AC et al. AHA Science Advisory: omega-3 fatty acids for the management of hypertriglyceridemia. Circulation 2019;140:e673-e691.\u003c\/li\u003e\n  \u003cli\u003eHarris WS, von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 2004;39(1):212-220.\u003c\/li\u003e\n  \u003cli\u003eHarris WS et al. Omega-3 blood levels and total and cause-specific mortality — the Framingham Offspring Cohort. J Clin Lipidol 2018;12(3):718-727.\u003c\/li\u003e\n  \u003cli\u003eDyerberg J et al. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot Essent Fatty Acids 2010;83(3):137-141. (rTG vs EE absorption.)\u003c\/li\u003e\n  \u003cli\u003eNeubronner J et al. Enhanced increase of Omega-3 Index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters. Eur J Clin Nutr 2011;65(2):247-254.\u003c\/li\u003e\n  \u003cli\u003eYurko-Mauro K et al. \u003cem\u003eMIDAS\u003c\/em\u003e: Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 2010;6(6):456-464.\u003c\/li\u003e\n  \u003cli\u003ePottala JV et al. Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes — WHIMS-MRI study. Neurology 2014;82(5):435-442.\u003c\/li\u003e\n  \u003cli\u003eSmith AD et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment. PLoS One 2010;5(9):e12244. (Omega-3 baseline as treatment-effect modifier.)\u003c\/li\u003e\n  \u003cli\u003eMocking RJT et al. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl Psychiatry 2016;6:e756.\u003c\/li\u003e\n  \u003cli\u003eMaroon JC, Bost JW. Omega-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to non-steroidal anti-inflammatory drugs for discogenic pain. Surg Neurol 2006;65(4):326-331.\u003c\/li\u003e\n  \u003cli\u003eCalder PC. Omega-3 fatty acids and inflammatory processes. Biochem Soc Trans 2017;45(5):1105-1115.\u003c\/li\u003e\n  \u003cli\u003eSerhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature 2014;510:92-101.\u003c\/li\u003e\n  \u003cli\u003eBurdge GC. Conversion of α-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Br J Nutr 2002;88(4):411-420.\u003c\/li\u003e\n  \u003cli\u003eParker HM et al. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 2012;56(4):944-951.\u003c\/li\u003e\n  \u003cli\u003eWachira JK et al. Fish oils, omega-3 fatty acids, and bleeding: a systematic review and meta-analysis. Mayo Clin Proc 2014.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2\u003eReading on this catalog’s blog\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/the-foundational-four-supplements-of-healthspan\"\u003eThe Foundational Four: omega-3, vitamin D, magnesium, and the GlyNAC pair\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/the-omega-3-index-and-why-it-matters\"\u003eThe Omega-3 Index — the only blood marker that actually measures fish oil status\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/triglyceride-vs-ethyl-ester-fish-oil\"\u003eTriglyceride vs ethyl ester: why the form on the label is non-negotiable\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/cardiovascular-supplement-stack\"\u003eThe cardiovascular pairing stack — omega-3, CoQ10, magnesium, taurine, vitamin K2\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/membrane-fluidity-and-aging\"\u003eMembrane fluidity and aging: why every NAD+ stack assumes omega-3 substrate\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Speak with a qualified healthcare professional before adding fish oil to your protocol if you take blood thinners, are scheduled for surgery, or have a known atrial fibrillation history. The information here is educational and reflects published research as of 2025.\u003c\/em\u003e\u003c\/p\u003e","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47839533596890,"sku":"THP-OMEGA3-2000-60","price":24.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_omega-3.png?v=1778047681","url":"https:\/\/truehealthprotocol.health\/products\/omega-3-fish-oil-2000mg-epa-dha","provider":"True Health Protocol","version":"1.0","type":"link"}